NLM Digital Collections

Search

Start Over Subjects Medicare Part D -- economics ✖Remove constraint Subjects: Medicare Part D -- economics Copyright Public domain ✖Remove constraint Copyright: Public domain

2. Questionable billing for compounded topical drugs in Medicare Part D

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2018
Subject(s):
Dermatologic Agents -- economics
Dermatologic Agents -- therapeutic use
Drug Compounding -- economics
Drug Utilization -- trends
Fraud
Insurance, Health, Reimbursement
Medicare Part D -- economics
Skin Cream -- economics
Administration, Topical
Dermatologic Agents -- adverse effects
Drug Compounding -- standards
Forecasting
Health Expenditures -- trends
Insurance Coverage
Skin Cream -- adverse effects
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

4. Federal mandatory spending for means-tested programs, 2008 to 2028

Publication:
Washington, D.C. : Congressional Budget Office, June 2018
Subject(s):
Federal Government
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicare -- economics
Cost Sharing
Food Assistance -- economics
Forecasting
Mandatory Programs -- economics
Medicare Part D -- economics
Humans
United States
United States.

5. Prices for and spending on specialty drugs in Medicare Part D and Medicaid: an in-depth analysis

Author(s):
Anderson-Cook, Anna, author
Maeda, Jared, author
Nelson, Lyle, author
Publication:
[Washington, DC] : Congressional Budget Office, March 2019
Subject(s):
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs
Economics, Pharmaceutical -- trends
Forecasting
Medicaid -- trends
Medicare Part D -- trends
Orphan Drug Production -- economics
Humans
United States

6. Prices for and spending on specialty drugs in Medicare Part D and Medicaid

Publication:
[Washington, DC] : Congressional Budget Office, March 2019
Subject(s):
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs
Economics, Pharmaceutical -- trends
Forecasting
Medicaid -- trends
Medicare Part D -- trends
Orphan Drug Production -- economics
Humans
United States

7. The Medicare drug benefit coverage gap: the basics

Publication:
Washington, D.C. : George Washington University, [2011]
Subject(s):
Insurance Coverage -- economics
Insurance Coverage -- legislation & jurisprudence
Insurance, Pharmaceutical Services -- economics
Insurance, Pharmaceutical Services -- legislation & jurisprudence
Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
Drug Costs -- statistics & numerical data
Drug Prescriptions -- economics
Financing, Personal -- economics
Financing, Personal -- legislation & jurisprudence
Humans
United States

8. Part D plans generally include drugs commonly used by dual eligibles: 2017

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2017
Subject(s):
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Insurance Coverage
Medicare Part D -- statistics & numerical data
Drug Utilization
Medicare Part D -- economics
Humans
United States
United States. Department of Health and Human Services.
United States.

9. Prescription opioids: Medicare should expand oversight efforts to reduce the risk of harm : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, January 17, 2018
Subject(s):
Drug and Narcotic Control
Inappropriate Prescribing -- prevention & control
Medicare Part D -- statistics & numerical data
Opioid-Related Disorders
Prescription Drug Misuse -- statistics & numerical data
Analgesics, Opioid -- adverse effects
Fraud -- prevention & control
Government Regulation
Inappropriate Prescribing -- statistics & numerical data
Medicare Part D -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

10. Inflation Reduction Act research series: Medicare Part D enrollee savings from elimination of vaccine cost-sharing

Author(s):
Sayed, Bisma A., author
Finegold, Kenneth, 1957- author
Ashok, Kaavya, author
Schutz, Sarah, author
De Lew, Nancy, author
Sheingold, Steven, author
Sommers, Benjamin D., author
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, March 15, 2023
Subject(s):
Cost Savings
Cost Sharing -- economics
Medicare Part D -- economics
Vaccines -- economics
United States
United States. Inflation Reduction Act.